1. Toxins are a luxury item (cosmetic) 2. FDA approval could be delayed 3. Company has several long term clinical trials that may be delayed by patient compliance especially the aesthetic trials 4. Large cash burn
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.